niacinamide has been researched along with Polycystic Ovary Syndrome in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Nejabati, HR | 3 |
| Samadi, N | 2 |
| Roshangar, L | 2 |
| Nouri, M | 3 |
| Shahnazi, V | 2 |
| Mihanfar, A | 1 |
| Fattahi, A | 1 |
| Latifi, Z | 1 |
| Bahrami-Asl, Z | 2 |
| Schmeisser, K | 1 |
| Samimifar, D | 1 |
| Faridvand, Y | 1 |
| Fathi-Maroufi, N | 1 |
| Nikanfar, S | 1 |
2 reviews available for niacinamide and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome.
Topics: Biomarkers; Cardiovascular Diseases; Female; Humans; Niacinamide; Polycystic Ovary Syndrome; Prodrom | 2019 |
N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin?
Topics: Aging; AMP-Activated Protein Kinases; Animals; Female; Humans; Niacinamide; Polycystic Ovary Syndrom | 2020 |
1 other study available for niacinamide and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Nicotinamide and its metabolite N1-Methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cytokines; Estrous Cycle; Female; Gene Expre | 2020 |